Bank of America Spends $250 Million a Year on Ozempic and Other GLP-1 Drugs, CEO Calls It 'a Good Investm

Bank of America spending $250M a year on GLP-1 weight loss drugs

Bank of America allocates $250M/year to GLP-1 drugs (13% of healthcare budget) for 211k employees. Corporate GLP-1 adoption signals healthcare cost shifts—tech managers must budget this growing line item as drugmakers expand employer coverage.